SRTA — Strata Critical Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $360.14m
- $298.90m
- $197.14m
Annual cashflow statement for Strata Critical Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 September 30th | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 15 M | 12 M | 12 M | 12 M | — |
| Source: | 10-K | 10-K | 10-K | 10-K | |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -39.3 | -27.3 | -56.1 | -27.3 | — |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 21.7 | -14.8 | 24.8 | 22.2 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.62 | -0.017 | -6.74 | -3.13 | — |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -21.6 | -37.1 | -32.3 | -2.52 | — |
| Capital Expenditures | -0.521 | -0.73 | -2.11 | -33 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -316 | 80.1 | 19.2 | 32 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -317 | 79.3 | 17.1 | -1.02 | — |
| Financing Cash Flow Items | 330 | -1.17 | -0.146 | -5.68 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 329 | -1.08 | -0.076 | -5.76 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9.05 | 41.2 | -15.4 | -9.37 | — |